Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 23,358 shares at $0.06 ($72K) on 2024-09-19, disclosed to the SEC on 2024-09-20.
Open-market purchase of $72k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.06 | 11,679 | $714 | 1.0% |
| 2 | $6.11 | 11,679 | $71K | 99.0% |
| Total | $3.09 avg | 23,358 | $72K | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |